SCHEMBL32688170

SCHEMBL32688170

N#Cc1c(-c2cccc(N3CCCC3=O)c2)cc(=O)[nH]c1S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.48
▸ BRDT Q58F21 1/20 0.48
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ RECQL P46063 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PARP1 P09874 3/20 0.39
▸ NPC1 O15118 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TSHR P16473 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687988 0.89 PRKAB2 (0.43) BRD4BRDTALDH1A1HPGDCYP3A4
SCHEMBL32688048 0.86 BRD4 (0.38) BRD4BRDTALDH1A1HPGDKDM4E
SCHEMBL32688309 0.84 KDM4E (0.43) ALDH1A1HPGDMEN1KMT2AGAA
SCHEMBL32688188 0.83 KDM4E (0.42) ALDH1A1MEN1KMT2AKDM4ERECQL
SCHEMBL32688129 0.81 KDM4E (0.42) ALDH1A1HPGDCYP3A4CYP2C9CYP2C19
SCHEMBL32688315 0.79 CHEK1 (0.45) CYP1A2KDM4ERECQLTDP1
SCHEMBL32688176 0.75 USP2 (0.47) ALDH1A1HPGDCYP3A4CYP2C9CYP2C19
SCHEMBL32688076 0.74 KDM4E (0.50) ALDH1A1HPGDCYP2C9CYP1A2MEN1
SCHEMBL20339404 0.73 ATM (0.58) ALDH1A1HPGDCYP3A4CYP2C9CYP2C19
SCHEMBL20340038 0.73 KDM4E (0.56) ALDH1A1HPGDMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK BRD4 3710/4885BRDT 913/4885ALDH1A1 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback